NASDAQ:LENZ | Cash Flow Statement | LENZ Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$31.92M
2026-03-31-$41.49M$111,000.00-$33.58M$18,000.00$33.16M$14,000.00
2025-12-31-$35.9M$107,000.00-$33.03M$38,000.00-$89.81M$122.62M
2025-09-30-$16.7M
2025-06-30-$14.91M
2025-03-31-$14.62M$36,000.00-$16.05M$110,000.00$18.89M$44,000.00
2024-12-31-$12.65M$25,000.00-$9.08M$149,000.00-$11.86M$53,000.00
2024-09-30-$10.22M
2024-06-30-$10.25M
2024-03-31-$16.65M$5,000.00-$23.94M$0.00$18M$171.27M
2023-12-31-$23.69M$4,000.00-$20.97M$0.00$15.17M-$1.91M
2023-09-30-$18.88M
2023-06-30-$14.73M
2023-03-31-$12.67M$3,000.00-$12.8M$6,000.00-$6,000.00$83.18M
2022-12-31-$24.6M-$22.43M$1.02M$13.52M$244,000.00
2022-09-30-$24.68M
2022-06-30-$25.94M
2022-03-31-$25.84M-$21.24M$3.27M-$170.67M$0.00
2021-12-31-$18.93M-$15.59M$981,000.00-$981,000.00$313,000.00
2021-09-30-$14.59M
2021-06-30-$17.53M
2021-03-31-$19.71M-$8.06M$360,000.00-$360,000.00$165.77M
2020-12-31-$63.54M-$5.27M$612,000.00-$612,000.00$15.12M
2020-09-30-$3.38M
2020-06-30-$1.31M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$82.13M$287,000.00-$69.17M$827,000.00-$75.67M$149.75M
2024-12-31-$49.77M$58,000.00-$59.39M$468,000.00-$154.48M$199M
2023-12-31-$69.97M$15,000.00-$60.38M$30,000.00-$29.62M$80.7M
2022-12-31-$101.05M-$87.98M$6.59M-$241.86M$597,000.00
2021-12-31-$70.76M-$52.85M$5.74M-$5.74M$417.47M
2020-12-31-$68.37M-$8.72M$1.55M-$1.55M$30.08M